cardiovascular treatment

Cerenis Raises €10 Million To Close €50 Million Financing

Cerenis Therapeutics, a pharma startup researching new cardiovascular therapies based on HDL, the so-called good cholesterol, said it has raised a further €10 million in a second close of its Series C financing. This takes […]

10/21/2010

Follow

Get every new post delivered to your Inbox.

Join 2,339 other followers